9 results on '"Frederico M. Farin"'
Search Results
2. Exercise training in transgenic mice is associated with attenuation of early breast cancer growth in a dose-dependent manner.
- Author
-
Jorming Goh, Jesse Tsai, Theo K Bammler, Frederico M Farin, Emma Endicott, and Warren C Ladiges
- Subjects
Medicine ,Science - Abstract
Epidemiological research suggests that regular physical activity confers beneficial effects that mediate an anti-tumor response and may reduce cancer recurrence. It is unclear what amount of physical activity is necessary to exert such a protective effect and what mechanisms are involved. We investigated the effects of voluntary wheel running on tumor progression and cytokine gene expression in the transgenic polyoma middle T oncoprotein (PyMT) mouse model of invasive breast cancer. Runners showed significantly reduced tumor sizes compared with non-runners after 3 weeks of running (p ≤ 0.01), and the greater the running distance the smaller the tumor size (Pearson's r = -0.61, p ≤ 0.04, R(2) = 0.38). Mice running greater than 150 km per week had a significantly attenuated tumor size compared with non-runners (p ≤ 0.05). Adipose tissue mass was inversely correlated with tumor size in runners (Pearson's r = -0.77, p = 0.014) but not non-runners. Gene expression of CCL22, a cytokine associated with recruitment of immunosuppressive T regulatory cells, was decreased in tumors of runners compared to non-runners (p ≤ 0.005). No differences in tumor burden or metastatic burden were observed between runners and non-runners after ten weeks of running when the study was completed. We conclude that voluntary wheel running in PyMT mice correlates with an attenuation in tumor progression early during the course of invasive breast cancer. This effect is absent in the later stages of overwhelming tumor burden even though cytokine signaling for immunosuppressive regulatory T cells was down regulated. These observations suggest that the initiation of moderate exercise training for adjunctive therapeutic benefit early in the course of invasive breast cancer should be considered for further investigation.
- Published
- 2013
- Full Text
- View/download PDF
3. A novel antibody-based biomarker for chronic algal toxin exposure and sub-acute neurotoxicity.
- Author
-
Kathi A Lefebvre, Elizabeth R Frame, Frances Gulland, John D Hansen, Preston S Kendrick, Richard P Beyer, Theo K Bammler, Frederico M Farin, Emma M Hiolski, Donald R Smith, and David J Marcinek
- Subjects
Medicine ,Science - Abstract
The neurotoxic amino acid, domoic acid (DA), is naturally produced by marine phytoplankton and presents a significant threat to the health of marine mammals, seabirds and humans via transfer of the toxin through the foodweb. In humans, acute exposure causes a neurotoxic illness known as amnesic shellfish poisoning characterized by seizures, memory loss, coma and death. Regular monitoring for high DA levels in edible shellfish tissues has been effective in protecting human consumers from acute DA exposure. However, chronic low-level DA exposure remains a concern, particularly in coastal and tribal communities that subsistence harvest shellfish known to contain low levels of the toxin. Domoic acid exposure via consumption of planktivorous fish also has a profound health impact on California sea lions (Zalophus californianus) affecting hundreds of animals yearly. Due to increasing algal toxin exposure threats globally, there is a critical need for reliable diagnostic tests for assessing chronic DA exposure in humans and wildlife. Here we report the discovery of a novel DA-specific antibody response that is a signature of chronic low-level exposure identified initially in a zebrafish exposure model and confirmed in naturally exposed wild sea lions. Additionally, we found that chronic exposure in zebrafish caused increased neurologic sensitivity to DA, revealing that repetitive exposure to DA well below the threshold for acute behavioral toxicity has underlying neurotoxic consequences. The discovery that chronic exposure to low levels of a small, water-soluble single amino acid triggers a detectable antibody response is surprising and has profound implications for the development of diagnostic tests for exposure to other pervasive environmental toxins.
- Published
- 2012
- Full Text
- View/download PDF
4. Differential expression of extracellular matrix-mediated pathways in single-suture craniosynostosis.
- Author
-
Brendan D Stamper, Sarah S Park, Richard P Beyer, Theo K Bammler, Frederico M Farin, Brig Mecham, and Michael L Cunningham
- Subjects
Medicine ,Science - Abstract
Craniosynostosis is a disease defined by premature fusion of one or more cranial sutures. The mechanistic pathology of single-suture craniosynostosis is complex and while a number of genetic biomarkers and environmental predispositions have been identified, in many cases the causes remain controversial and inconclusive. In this study, gene expression data from 199 patients with isolated sagittal (n = 100), unilateral coronal (n = 50), and metopic (n = 49) synostosis are compared against both a control population (n = 50), as well as each other. After controlling for variables contributing to potential bias, FGF7, SFRP4, and VCAM1 emerged as genes associated with single-suture craniosynostosis due to their significantly large changes in gene expression compared to the control population. Pathway analysis implicated focal adhesion and extracellular matrix (ECM)-receptor interaction as differentially regulated gene networks when comparing all cases of single-suture synostosis and controls. Lastly, overall gene expression was found to be highly conserved between coronal and metopic cases, as evidenced by the fact that WNT2 and IGFBP2 were the only genes differentially regulated to a significantly large extent in a direct comparison. The identification of genes and gene networks associated with Fgf/Igf/Wnt signaling and ECM-mediated focal adhesion not only support the involvement of biomarkers previously reported to be related to craniosynostosis, but also introduce novel transcripts and pathways that may play critical roles in its pathogenesis.
- Published
- 2011
- Full Text
- View/download PDF
5. p53 Contributes to Differentiating Gene Expression Following Exposure to Acetaminophen and Its Less Hepatotoxic Regioisomer Both In Vitro and In Vivo
- Author
-
Brendan D. Stamper, Michael L. Garcia, Duy Q. Nguyen, Richard P. Beyer, Theo K. Bammler, Frederico M. Farin, Terrance J. Kavanagh, and Sidney D. Nelson
- Subjects
lcsh:Biology (General) ,lcsh:QH301-705.5 - Published
- 2015
6. p53 Contributes to Differentiating Gene Expression following Exposure to Acetaminophen and Its Less Hepatotoxic Regioisomer Both and
- Author
-
Brendan D. Stamper, Michael L. Garcia, Duy Q. Nguyen, Richard P. Beyer, Theo K. Bammler, Frederico M. Farin, Terrance J. Kavanagh, and Sidney D. Nelson
- Subjects
lcsh:Biology (General) ,digestive, oral, and skin physiology ,lcsh:QH301-705.5 - Abstract
The goal of the present study was to compare hepatic toxicogenomic signatures across in vitro and in vivo mouse models following exposure to acetaminophen (APAP) or its relatively nontoxic regioisomer 3′-hydroxyacetanilide (AMAP). Two different Affymetrix microarray platforms and one Agilent Oligonucleotide microarray were utilized. APAP and AMAP treatments resulted in significant and large changes in gene expression that were quite disparate, and likely related to their different toxicologic profiles. Ten transcripts, all of which have been implicated in p53 signaling, were identified as differentially regulated at all time-points following APAP and AMAP treatments across multiple microarray platforms. Protein-level quantification of p53 activity aligned with results from the transcriptomic analysis, thus supporting the implicated mechanism of APAP-induced toxicity. Therefore, the results of this study provide good evidence that APAP-induced p53 phosphorylation and an altered p53-driven transcriptional response are fundamental steps in APAP-induced toxicity.
- Published
- 2015
7. A Novel Antibody-Based Biomarker for Chronic Algal Toxin Exposure and Sub-Acute Neurotoxicity
- Author
-
David J. Marcinek, Frances M. D. Gulland, Donald R. Smith, Elizabeth R. Frame, J. D. Hansen, Theo K. Bammler, Frederico M. Farin, Preston S. Kendrick, Kathi A. Lefebvre, Emma M. Hiolski, and Richard P. Beyer
- Subjects
Veterinary Toxicology ,Physiology ,lcsh:Medicine ,Marine and Aquatic Sciences ,medicine.disease_cause ,Toxicology ,0403 veterinary science ,chemistry.chemical_compound ,lcsh:Science ,Zebrafish ,0303 health sciences ,Multidisciplinary ,Kainic Acid ,Ecology ,Domoic acid ,04 agricultural and veterinary sciences ,Animal Models ,3. Good health ,Sea Lions ,Veterinary Diseases ,Toxicity ,Medicine ,Research Article ,Neurotoxicology ,040301 veterinary sciences ,Toxic Agents ,Marine Biology ,Biology ,Algal bloom ,03 medical and health sciences ,Model Organisms ,Amnesic shellfish poisoning ,medicine ,Animals ,Humans ,14. Life underwater ,Shellfish ,030304 developmental biology ,Toxin ,lcsh:R ,Neurotoxicity ,medicine.disease ,chemistry ,Antibody Formation ,Earth Sciences ,lcsh:Q ,Veterinary Science ,Marine Toxins ,Marine toxin ,Biomarkers - Abstract
The neurotoxic amino acid, domoic acid (DA), is naturally produced by marine phytoplankton and presents a significant threat to the health of marine mammals, seabirds and humans via transfer of the toxin through the foodweb. In humans, acute exposure causes a neurotoxic illness known as amnesic shellfish poisoning characterized by seizures, memory loss, coma and death. Regular monitoring for high DA levels in edible shellfish tissues has been effective in protecting human consumers from acute DA exposure. However, chronic low-level DA exposure remains a concern, particularly in coastal and tribal communities that subsistence harvest shellfish known to contain low levels of the toxin. Domoic acid exposure via consumption of planktivorous fish also has a profound health impact on California sea lions (Zalophus californianus) affecting hundreds of animals yearly. Due to increasing algal toxin exposure threats globally, there is a critical need for reliable diagnostic tests for assessing chronic DA exposure in humans and wildlife. Here we report the discovery of a novel DA-specific antibody response that is a signature of chronic low-level exposure identified initially in a zebrafish exposure model and confirmed in naturally exposed wild sea lions. Additionally, we found that chronic exposure in zebrafish caused increased neurologic sensitivity to DA, revealing that repetitive exposure to DA well below the threshold for acute behavioral toxicity has underlying neurotoxic consequences. The discovery that chronic exposure to low levels of a small, water-soluble single amino acid triggers a detectable antibody response is surprising and has profound implications for the development of diagnostic tests for exposure to other pervasive environmental toxins.
- Published
- 2012
8. Comparison of the Cytotoxicity of the Nitroaromatic Drug Flutamide to Its Cyano Analogue in the Hepatocyte Cell Line TAMH: Evidence for Complex I Inhibition and Mitochondrial Dysfunction Using Toxicogenomic Screening
- Author
-
Han Kiat Ho, Kevin J. Coe, Libby Woodke, Stephen R. Plymate, Frederico M. Farin, Sidney D. Nelson, Richard P. Beyer, Peter M. Rademacher, Yankai Jia, Theo K. Bammler, and Nelson Fausto
- Subjects
Male ,Programmed cell death ,Cell Survival ,Oxidative phosphorylation ,Mitochondrion ,Pharmacology ,Biology ,Toxicology ,Article ,Lethal Dose 50 ,Mice ,Adenosine Triphosphate ,Cell Line, Tumor ,Nitriles ,medicine ,Animals ,Humans ,Viability assay ,Cytotoxicity ,Electron Transport Complex I ,Dose-Response Relationship, Drug ,Molecular Structure ,virus diseases ,Prostatic Neoplasms ,Androgen Antagonists ,General Medicine ,medicine.disease ,Microarray Analysis ,Nitro Compounds ,Flutamide ,respiratory tract diseases ,Mitochondria ,Mitochondrial toxicity ,medicine.anatomical_structure ,Gene Expression Regulation ,Hepatocyte ,Toxicity ,Hepatocytes ,Drug Screening Assays, Antitumor - Abstract
Flutamide (FLU) is an antiandrogen primarily used in the treatment of metastatic prostate cancer. It is an idiosyncratic hepatotoxicant that sometimes results in severe liver toxicity. FLU possesses a nitroaromatic group, which may be a contributor to its mechanism of toxicity. A nitro to cyano analogue of FLU (CYA) was synthesized and used to test this hypothesis in the TGFalpha-transfected mouse hepatocyte cell line (TAMH). MTT cell viability assays and confocal microscopy showed that hepatocytes are more sensitive to cytotoxicity caused by FLU than CYA (LD 50 75 vs 150 microM, respectively). Despite the structural modification, the antiandrogen activity of CYA is comparable to that of FLU. Comparisons of transcriptomic changes caused by FLU with those caused by a panel of known cytotoxicants [acetaminophen, tetrafluoroethylcysteine, diquat, and rotenone (ROT)] indicated that FLU results in a temporal gene expression pattern similar to ROT, a known inhibitor of complex I of the electron transport chain. A subsequent microarray analysis comparing FLU to CYA and ROT revealed many similarities among these three compounds; however, FLU and ROT result in more substantial changes than CYA in the expression of genes associated with oxidative phosphorylation, fatty acid beta-oxidation, antioxidant defense, and cell death pathways. Electron microscopy confirmed that FLU leads to mitochondrial toxicity that has some similarities to the mitochondrial effects of ROT, but the morphologic changes caused by FLU were greater in scope with both intra- and intercellular manifestations. Biochemical studies confirmed that both ROT and FLU deplete cellular ATP levels and inhibit complex I of the electron transport chain to a greater extent than CYA. Thus, as compared to CYA, the nitroaromatic group of FLU enhances cytotoxicity to hepatocytes, likely through mechanisms involving mitochondrial dysfunction and ATP depletion that include complex I inhibition.
- Published
- 2007
9. Comparison of the Cytotoxicity of the Nitroaromatic Drug Flutamide to Its Cyano Analogue in the Hepatocyte Cell Line TAMH: Evidence for Complex I Inhibition and Mitochondrial Dysfunction Using Toxicogenomic Screening.
- Author
-
Kevin J. Coe, Yankai Jia, Han Kiat Ho, Peter Rademacher, Theo K. Bammler, Richard P. Beyer, Frederico M. Farin, Libby Woodke, Stephen R. Plymate, Nelson Fausto, and Sidney D. Nelson
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.